Literature DB >> 33398492

Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment.

Saeid Bagheri-Mohammadi1,2,3.   

Abstract

Alzheimer's disease (AD) is a neuronal disorder with insidious onset and slow progression, leading to growing global concern with huge implications for individuals and society. The occurrence of AD has been increased and has become an important health issue throughout the world. In recent years, the care of more than 35 million patients with AD costs over $ 600 billion per year, it is approximately 1 percent of the global Gross Domestic Product. Currently, the therapeutic approach is not effective for neurological deficits especially after the development of these major neurological disorders. The discovery of the technique called cell-based therapy has shown promising results and made important conclusions beyond AD using the stem cells approach. Here we review recent progress on stem cell-based therapy in the context of AD.

Entities:  

Keywords:  Alzheimer's disease; Cell therapy; Hippocampus; Mesenchymal stem cells; Stem cells

Year:  2021        PMID: 33398492     DOI: 10.1007/s10561-020-09896-3

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  99 in total

1.  Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF.

Authors:  Soshana Behrstock; Allison D Ebert; Sandra Klein; Melanie Schmitt; Jeannette M Moore; Clive N Svendsen
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

Review 2.  Therapeutic potential of human adipose-derived stem cells in neurological disorders.

Authors:  Keun-A Chang; Jun-Ho Lee; Yoo-Hun Suh
Journal:  J Pharmacol Sci       Date:  2014-11-18       Impact factor: 3.337

3.  Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.

Authors:  Saeid Bagheri-Mohammadi; Behrang Alani; Mohammad Karimian; Rana Moradian-Tehrani; Mahdi Noureddini
Journal:  Mol Biol Rep       Date:  2019-05-23       Impact factor: 2.316

Review 4.  Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection.

Authors:  Filippo Caraci; Simona Spampinato; Maria Angela Sortino; Paolo Bosco; Giuseppe Battaglia; Valeria Bruno; Filippo Drago; Ferdinando Nicoletti; Agata Copani
Journal:  Cell Tissue Res       Date:  2011-08-31       Impact factor: 5.249

5.  Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease.

Authors:  Allal Boutajangout; Abdulwahab Noorwali; Hazem Atta; Thomas Wisniewski
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 6.  Stem cell-based therapy for Parkinson's disease with a focus on human endometrium-derived mesenchymal stem cells.

Authors:  Saeid Bagheri-Mohammadi; Mohammad Karimian; Behrang Alani; Javad Verdi; Rana Moradian Tehrani; Mahdi Noureddini
Journal:  J Cell Physiol       Date:  2018-08-26       Impact factor: 6.384

7.  CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology.

Authors:  Elizabeth M Bradshaw; Lori B Chibnik; Brendan T Keenan; Linda Ottoboni; Towfique Raj; Anna Tang; Laura L Rosenkrantz; Selina Imboywa; Michelle Lee; Alina Von Korff; Martha C Morris; Denis A Evans; Keith Johnson; Reisa A Sperling; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Nat Neurosci       Date:  2013-05-23       Impact factor: 24.884

8.  Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.

Authors:  Mathew Blurton-Jones; Masashi Kitazawa; Hilda Martinez-Coria; Nicholas A Castello; Franz-Josef Müller; Jeanne F Loring; Tritia R Yamasaki; Wayne W Poon; Kim N Green; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-24       Impact factor: 11.205

Review 9.  Cell therapy for Parkinson's disease: what next?

Authors:  Anders Bjorklund; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2013-01       Impact factor: 10.338

10.  Short-term environmental enrichment, in the absence of exercise, improves memory, and increases NGF concentration, early neuronal survival, and synaptogenesis in the dentate gyrus in a time-dependent manner.

Authors:  Amy M Birch; Niamh B McGarry; Aine M Kelly
Journal:  Hippocampus       Date:  2013-03-05       Impact factor: 3.899

View more
  2 in total

1.  Cinnamaldehyde Regulates Insulin and Caspase-3 Signaling Pathways in the Sporadic Alzheimer's Disease Model: Involvement of Hippocampal Function via IRS-1, Akt, and GSK-3β Phosphorylation.

Authors:  Saeid Bagheri-Mohammadi; Sahar Askari; Behrang Alani; Maryam Moosavi; Rasoul Ghasemi
Journal:  J Mol Neurosci       Date:  2022-10-10       Impact factor: 2.866

Review 2.  Adult Hippocampal Neurogenesis and Alzheimer's Disease: Novel Application of Mesenchymal Stem Cells and their Role in Hippocampal Neurogenesis.

Authors:  Mahdi Noureddini; Saeid Bagheri-Mohammadi
Journal:  Int J Mol Cell Med       Date:  2021-05-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.